Additionally, IGFBP6 has shown to promote the activation of the Toll-like receptor 4 (TLR4) signaling pathway and aggravate myelofibrosis by regulating the Sonic Hedgehog (SHH) signaling cascade 17. The gene discussed is TLR4; the disease is myelofibrosis.